AngioCloud Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
AngioCloud General Information
Description
Developer of 3D imaging software designed to analyze 3D vascular images. The company's software allows any connected device to share high-quality images and collaborate on 3D vascular cases to support diagnosis, pre-surgical planning, medical device selection, and e-clinical trial administration, enabling surgeons to analyze to carry out surgical processes with ease and flexibility.
Contact Information
Website
www.angiocloud.comCorporate Office
- 1 Glenlake Parkway
- Suite 200
- Atlanta, GA 30328-7269
- United States
Corporate Office
- 1 Glenlake Parkway
- Suite 200
- Atlanta, GA 30328-7269
- United States
AngioCloud Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 19-Dec-2024 | Completed | Out of Business | |||
| 2. Grant | 02-Mar-2020 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Startup |
AngioCloud FAQs
-
Where is AngioCloud headquartered?
AngioCloud is headquartered in Atlanta, GA.
-
What industry is AngioCloud in?
AngioCloud’s primary industry is Decision/Risk Analysis.
-
Is AngioCloud a private or public company?
AngioCloud is a Private company.
-
What is AngioCloud’s current revenue?
The current revenue for AngioCloud is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process